Total Utang marang Modal Anbio (NNNN)

NNNN (anbio.com) - tandha merek perusahaan

Anbio Biotechnology (NNNN) is attracting leading molecular experts and biochemists to develop its R&D center, maintaining a stable workforce. The business relies on global shipments of diagnostic systems to clinics of various scales, which minimizes regional risks. The debt-to-equity ratio stands at 0.00, complementing this price chart illustrating valuation trends and confirming the developer's status as a provider of affordable AI analyzers for rapid diagnostics.

NNNN: Rasio Utang marang Ekuitas anbio.com 20.02.2025 - 29.10.2026

Rincian analitis perusahaan Anbio Corp (NNNN)

- rega lan prakiraan konsensus rega:
Bagan rega Anbio|NNNN - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Anbio Biotechnology|NNNN - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Anbio Biotechnology|NNNN - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku anbio.com|NNNN - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Anbio Biotechnology|NNNN - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Anbio Biotechnology|NNNN - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Anbio Biotechnology|NNNN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Anbio Biotechnology
Analisis dhasar perusahaan:NNNN, Anbio
Barang utama Anbio Corp

Amidst fierce competition in the IVD diagnostics sector, Anbio Biotechnology (NNNN) requires a balance between R&D investments and financial stability. This indicator measures the proportion of borrowed funds relative to equity, determining the business's level of dependence on creditors and the risk of default. By analyzing the company's debt-to-equity ratio, an investor can assess whether excessive conservatism is limiting the company's expansion pace.

Pesaing wigati

Utang marang Ekuitas Agilent|Rasio Total Utang marang Ekuitas Quest Diagnostics Inc. (DGX)|Total Utang marang Modal ILMN|EXAS - Utang marang Modal|Total Utang marang Modal RVTY (Revvity, Inc.)|BIO: Rasio Utang marang Ekuitas|Sotera Health - Total Utang marang Modal|QDEL - Total Utang marang Modal|OPKO Corp (OPK) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CDNA|MRVI (Maravai LifeSciences) - Total Utang marang Modal|Total Utang marang Modal fulgentgenetics.com|Utang marang Ekuitas Standard BioTools (LAB)|Utang marang Ekuitas CTKB (Cytek Biosciences Inc)|OraSure Technologies Inc - Rasio Total Utang marang Ekuitas|Exagen Inc (XGN) - Utang marang Modal|MDXH - Utang marang Ekuitas|Koefisien Total Utang marang Modal luciddx.com LUCD|PRE: Total Utang marang Modal|IMDX - Koefisien Total Utang marang Modal|Utang marang Ekuitas Trinity Biotech PLC|ProPhase Labs Corp (PRPH) - Koefisien Total Utang marang Modal|Total Utang marang Modal AIMD|Total Utang marang Modal codiagnostics.com (CODX)|Utang marang Ekuitas HeartSciences HSCS|BMRA: Rasio Utang marang Ekuitas|Cardio Diagnostics Holdings, Inc. - Total Utang marang Modal|VRAX: Utang marang Ekuitas|BJDX: Total Utang marang Modal|AWH - Koefisien Total Utang marang Modal|Utang marang Ekuitas Accelerate Diagnostics, Inc.|Utang marang Modal Centogene NV CNTG|Rasio Total Utang marang Ekuitas ENZ (Enzo Biochem, Inc.)|FRES (fresh2.co) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GENE (Genetic Technologies Limited)|23andme.com - Utang marang Ekuitas|Psychemedics Corporation - Total Utang marang Modal